Bio-Techne to Showcase RNAscope Advances at 2025 USCAP Meeting
Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet...